1. Home
  2. STWD vs PRAX Comparison

STWD vs PRAX Comparison

Compare STWD & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$18.03

Market Cap

7.4B

Sector

Real Estate

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$320.24

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
PRAX
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4B
9.6B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
STWD
PRAX
Price
$18.03
$320.24
Analyst Decision
Buy
Strong Buy
Analyst Count
4
15
Target Price
$20.13
$572.13
AVG Volume (30 Days)
3.2M
371.8K
Earning Date
05-26-2026
05-12-2026
Dividend Yield
10.67%
N/A
EPS Growth
4.55
N/A
EPS
1.15
N/A
Revenue
$1,844,289,000.00
N/A
Revenue This Year
$282.53
N/A
Revenue Next Year
$12.64
$1,840.20
P/E Ratio
$15.66
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.59
$26.70
52 Week High
$20.99
$354.87

Technical Indicators

Market Signals
Indicator
STWD
PRAX
Relative Strength Index (RSI) 47.85 50.06
Support Level $17.73 $290.36
Resistance Level $18.62 $322.32
Average True Range (ATR) 0.33 19.02
MACD 0.00 -2.10
Stochastic Oscillator 58.93 46.86

Price Performance

Historical Comparison
STWD
PRAX

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment, and Investing & Servicing Segment. The company generates the majority of its revenue from the Commercial and Residential Lending Segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: